Estimated incidence and genotypes of HIV-1 among pregnant women in Central Brazil

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Costa, Zelma Bernardes ^a   De Stefani, Mariane Martins Araujo ^a   De Lima, Yanna Andressa Ramos ^a   De Souza, Wayner Vieira ^b   De Siqueira Filha, Noemia Teixeira ^b   Turchi, Marilia Dalva ^a   Borges, Walter Costa ^a   Gomes Filho, Clidenor ^c   Macedo Filho, Jose Vicente ^d   Minuzzi, Ana Lucia ^d   Martelli, Celina Maria Turchi ^a,e  

^a FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c Health State Secretariat   (Brazil)

^d Associacao de Pais e Amigos Dos Excepcionais de Goiania APAE   (Brazil)

^e FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; BRAZIL; CROSS-SECTIONAL STUDY; ENZYME IMMUNOASSAY; FEMALE; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INCIDENCE; MAJOR CLINICAL STUDY; MATERNAL AGE; NONHUMAN; NUCLEOTIDE SEQUENCE; OBSERVATIONAL STUDY; PREGNANCY; PREGNANT WOMAN; PREVALENCE; PRIMIGRAVIDA; VIRUS STRAIN;

ADOLESCENT; ADULT; AGE FACTORS; AIDS SERODIAGNOSIS; BRAZIL; CHILD; CROSS-SECTIONAL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENOTYPE; HIV INFECTIONS; HIV-1; HUMANS; INCIDENCE; MASS SCREENING; PHYLOGENY; POL GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREVALENCE; YOUNG ADULT;

EID: 84892609755     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0079189     Document Type: Article

References (66)

1. UNAIDS (2012) UNAIDS Report on the global AIDS epidemic. Geneva. p. 106.
2. Bastos FI, Cáceres C, Galvão J, Veras MA, Castilho EA (2008) AIDS in Latin America: assessing the current status of the epidemic and the ongoing response. Int J Epidemiol 37: 729-737. PubMed: 18653508.
3. Brazil (2010) Boletim Epidemiológico, ano VII. In: Brasília: Ministério da Saúde.
4. Walker N, Grassly NC, Garnett GP, Stanecki KA, Ghys PD (2004) Estimating the global burden of HIV/AIDS: what do we really know about the HIV pandemic? Lancet 363: 2180-2185. doi:10.1016/S0140-6736(04)16511-2. PubMed: 15220043.
5. Malta M, Magnanini MM, Mello MB, Pascom AR, Linhares Y et al. (2010) HIV prevalence among female sex workers, drug users and men who have sex with men in Brazil: a systematic review and metaanalysis. BMC Public Health 10: 317. doi:10.1186/1471-2458-10-317. PubMed: 20529289.
6. Costa ZB, Machado GC, Avelino MM, Gomes Filho C, Macedo Filho JV et al. (2009) Prevalence and risk factors for Hepatitis C and HIV-1 infections among pregnant women in Central Brazil. BMC Infect Dis 9: 116. doi:10.1186/1471-2334- 9-116. PubMed: 19635135.
7. Szwarcwald CL, Souza PRB Jr (2006) Estimativa de prevalência de HIV na população brasileira de 15-49 anos, 2004. pp. 11-15.
8. Brookmeyer R (2010) Measuring the HIV/AIDS epidemic: approaches and challenges. Epidemiol Rev 32: 26-37. doi:10.1093/epirev/mxq002. PubMed: 20203104.
9. Barreto ML, Teixeira MG, Bastos FI, Ximenes RA, Barata RB et al. (2011) Successes and failures in the control of infectious diseases in Brazil: social and environmental context, policies, interventions, and research needs. Lancet 377: 1877-1889. doi:10.1016/S0140-6736(11)60202-X. PubMed: 21561657.
10. Dourado I, Veras MA, Barreira D, de Brito AM (2006) [AIDS epidemic trends after the introduction of antiretroviral therapy in Brazil]. Rev Saude Publica 40 Suppl: 9-17. doi:10.1590/S0034-89102006000800003. PubMed: 16729154.
11. Bastos FI, Nunn A, Hacker M, Malta M, Szwarcwald C (2008) AIDS in Brazil: the challenge and the response. In: DD CelentanoC Beyrer. Public Health Aspects of HIV/AIDS in Low and Middle Income Countries. New York: Springer Science and Business. Media: 629-654.
12. Gräf T, Pinto AR (2013) The increasing prevalence of HIV-1 subtype C in Southern Brazil and its dispersion through the continent. Virology 435: 170-178. doi:10.1016/j.virol.2012.08.048. PubMed: 22999094.
13. Alcântara KC, Lins JB, Albuquerque M, Aires LM, Cardoso LP et al. (2012) HIV-1 mother-to-child transmission and drug resistance among Brazilian pregnant women with high access to diagnosis and prophylactic measures. J Clin Virol 54: 15-20. doi:10.1016/j.jcv.2012.01.011. PubMed: 22317908.
14. Porco TC, Martin JN, Page-Shafer KA, Cheng A, Charlebois E et al. (2004) Decline in HIV infectivity following the introduction of highly active antiretroviral therapy. AIDS 18: 81-88. doi: 10.1097/00002030-200401020-00010. PubMed: 15090833.
15. Prejean J, Song R, Hernandez A, Ziebell R, Green T et al. (2011) Estimated HIV incidence in the United States, 2006-2009. PLOS ONE 6: e17502. doi:10.1371/journal.pone.0017502. PubMed: 21826193.
16. Nelson KE, Galai N, Safaeian M, Strathdee SA, Celentano DD et al. (2002) Temporal trends in the incidence of human immunodeficiency virus infection and risk behavior among injection drug users in Baltimore, Maryland, 1988-1998. Am J Epidemiol 156: 641-653. doi: 10.1093/aje/kwf086. PubMed: 12244033.
17. Tyndall MW, Craib KJ, Currie S, Li K, O'Shaughnessy MV et al. (2001) Impact of HIV infection on mortality in a cohort of injection drug users. J Acquir Immune Defic Syndr 28: 351-357. doi: 10.1097/00126334-200112010-00008. PubMed: 11707672.
18. UNAIDS (2011) UNAIDS World AIDS Day Report |. Geneva: U.N. AIDS. p. 2011 - Joint United Nations Programme on HIV/AIDS.
19. McDougal JS, Pilcher CD, Parekh BS, Gershy-Damet G, Branson BM et al. (2005) Surveillance for HIV-1 incidence using tests for recent infection in resource-constrained countries. AIDS 19 Suppl 2: S25-S30. doi:10.1097/00002030- 200501030-00003. PubMed: 15930838.
20. Le Vu S, Pillonel J, Semaille C, Bernillon P, Le Strat Y et al. (2008) Principles and uses of HIV incidence estimation from recent infection testing - a review. Euro Surveill 13: ([MedlinePgn:]) PubMed: 18775292.
21. Braunstein SL, van de Wijgert JH, Nash D (2009) HIV incidence in sub-Saharan Africa: a review of available data with implications for surveillance and prevention planning. AIDS Res 11: 140-156.
22. Fiamma A, Lissouba P, Amy OE, Singh B, Laeyendecker O et al. (2010) Can HIV incidence testing be used for evaluating HIV intervention programs? A reanalysis of the Orange Farm male circumcision trial (ANRS-1265). BMC Infect Dis 10: 137. doi: 10.1186/1471-2334-10-137. PubMed: 20507545.
23. Morgado MG, Bastos FI (2011) Estimates of HIV-1 incidence based on serological methods: a brief methodological review. Cad Saude Publica 27 Suppl 1: S7-18. doi:10.1590/S0102-311X2011001300002. PubMed: 21503527.
24. Parekh BS, Kennedy MS, Dobbs T, Pau CP, Byers R et al. (2002) Quantitative detection of increasing HIV type 1 antibodies after seroconversion: A simple assay for detecting recent HIV infection and estimating incidence. AIDS Res Hum Retrovir 18: 295-307. doi: 10.1089/088922202753472874. PubMed: 11860677.
25. de Castro CA, Grinsztejn B, Veloso VG, Bastos FI, Pilotto JH et al. (2010) Prevalence, estimated HIV-1 incidence and viral diversity among people seeking voluntary counseling and testing services in Rio de Janeiro, Brazil. BMC Infect Dis 10: 224. doi: 10.1186/1471-2334-10-224. PubMed: 20667113.
26. Lee LM, McKenna MT (2007) Monitoring the incidence of HIV infection in the United States. Public Health Rep 122 Suppl 1: 72-79. PubMed: 17354530.
27. Hall HI, Song R, Rhodes P, Prejean J, An Q et al. (2008) Estimation of HIV incidence in the United States. JAMA 300: 520-529. doi:10.1001/jama.300.5. 520. PubMed: 18677024.
28. Bätzing-Feigenbaum J, Loschen S, Gohlke-Micknis S, Zimmermann R, Herrmann A et al. (2008) Country-wide HIV incidence study complementing HIV surveillance in Germany. Euro Surveill 13: ([MedlinePgn:]) PubMed: 18775289.
29. Semaille C, Cazein F, Pillonel J, Lot F, Le Vu S et al. (2008) Four years of surveillance of recent HIV infections at country level, France, mid 2003 - 2006: experience and perspectives. Euro Surveill 13.
30. Cortes Martins H, Paixao M (2008) Settings for identifying recent HIV infections: the Portuguese experience. Euro Surveill 13: ([MedlinePgn:]) PubMed: 18775290.
31. Bassichetto KC, Bergamaschi DP, Veras MA, Sucupira MC, Mesquita F et al. (2009) Estimating HIV-1 incidence using the serologic testing algorithm for recent HIV infections at HIV counseling and testing centers in the city of Sao Paulo, Brazil. Braz J Infect Dis 13: 9-12. doi: 10.1590/S1413-86702009000100004. PubMed: 19578623.
32. Cavalcanti AM, Brito AM, Salustiano DM, Lima KO, Silva SP et al. (2012) Recent HIV infection rates among HIV positive patients seeking voluntary counseling and testing centers in the metropolitan region of Recife - PE, Brazil. Braz J Infect Dis 16: 157-163. doi:10.1016/S1413-8670(12)70298-2. PubMed: 22552458.
33. de Lima KO, Salustiano DM, Coêlho MR, Cavalcanti AM, Diaz RS et al. (2012) Incidence of recent human immunodeficiency virus infection at two voluntary counseling testing centers in Pernambuco, Brazil, from 2006 to 2009. J Clin Microbiol 50: 2145-2146. doi:10.1128/JCM.05107-11. PubMed: 22403429.
34. Oliveira CAF, Ueda M, Yamashiro R, Rodrigues R, Sheppard HW et al. (2005) Rate and incidence estimates of recent human immunodeficiency virus type 1 infections among pregnant women in Sao Paulo, Brazil, from 1991 to 2002. J Clin Microbiol 43: 1439-1442. doi:10.1128/JCM.43.3.1439-1442.2005. PubMed: 15750127.
35. IBGE (2010) Demographic Census 2010:characteristics of the population and households, results from the population universe.
36. Brazil (2010) Recomendações para a Profilaxia da Transmissão Vertical do HIV e Terapia Anti-Retroviral em Gestantes. In: PNd, DST/AIDS. Brasília: Ministério da Saúde.
37. Dobbs T, Kennedy S, Pau CP, McDougal JS, Parekh BS (2004) Performance characteristics of the immunoglobulin G-capture BED-enzyme immunoassay, an assay to detect recent human immunodeficiency virus type 1 seroconversion. J Clin Microbiol 42: 2623-2628. doi:10.1128/JCM.42.6.2623-2628.2004. PubMed: 15184443.
38. Brazil (2004) Recomendações para Profilaxia da Transmissão Vertical do HIV e Terapia Anti-Retroviral em Gestantes. In: Brasília, editor, DST/AIDS SdVeSPNd: Ministério da Saúde
39. Dobbs T, Liu X, Anderson R, Nkengasong J, Parekh BS (2011) A comprehensive evaluation of the proficiency testing program for the HIV-1 BED incidence assay. J Clin Microbiol 49: 3470-3473. doi: 10.1128/JCM.01122-11. PubMed: 21832016.
40. Frankel AD, Young JA (1998) HIV-1: fifteen proteins and an RNA. Annu Rev Biochem 67: 1-25. doi:10.1146/annurev.biochem.67.1.1. PubMed: 9759480.
41. Hall TA (1999) BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symp S 41: 95-98.
42. Tamura K, Dudley J, Nei M, Kumar S (2007) MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 24: 1596-1599. doi:10.1093/molbev/msm092. PubMed: 17488738.
43. Lole KS, Bollinger RC, Paranjape RS, Gadkari D, Kulkarni SS et al. (1999) Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination. J Virol 73: 152-160. PubMed: 9847317.
44. McDougal JS, Parekh BS, Peterson ML, Branson BM, Dobbs T et al. (2006) Comparison of HIV type 1 incidence observed during longitudinal follow-up with incidence estimated by cross-sectional analysis using the BED capture enzyme immunoassay. AIDS Res Hum Retrovir 22: 945-952. doi:10.1089/aid.2006.22.945. PubMed: 17067263.
45. Hargrove JW, Humphrey JH, Mutasa K, Parekh BS, McDougal JS et al. (2008) Improved HIV-1 incidence estimates using the BED capture enzyme immunoassay. AIDS 22: 511-518. doi:10.1097/QAD. 0b013e3282f2a960. PubMed: 18301064.
46. Turchi MD, Diaz RS, Martelli CM, Sabino EC, Da Silva WP et al. (2002) Genetic diversity and HIV-1 incidence estimation among cocaine users in Sao Paulo, Brazil. J Acquir Immune Defic Syndr 30: 527-532. doi: 10.1097/00126334-200208150-00009. PubMed: 12154344.
47. Teixeira SL, Bastos FI, Telles PR, Hacker MA, Brigido LF et al. (2004) HIV-1 infection among injection and ex-injection drug users from Rio de Janeiro, Brazil: prevalence, estimated incidence and genetic diversity. J Clin Virol 31: 221-226. doi:10.1016/j.jcv.2004.03.016. PubMed: 15465416.
48. Merçon M, Tuboi SH, Batista SM, Telles SR, Grangeiro JR et al. (2009) Risk-based assessment does not distinguish between recent and chronic HIV-1 infection in Rio de Janeiro, Brazil. Braz J Infect Dis 13: 272-275. PubMed: 20231989.
49. Almeida C, Travassos C, Porto S, Labra ME (2000) Health sector reform in Brazil: a case study of inequity. Int J Health Serv 30: 129-162. doi:10.2190/NDGW-C2DP-GNF8-HEW8. PubMed: 10707303.
50. Anderson RM, May RM (1991) Infectious Diseases of Humans - Dynamics and Control. New York: Oxford University Press.
51. Lopes F, Buchalla CM, Ayres JR (2007) [Black and non-Black women and vulnerability to HIV/AIDS in Sao Paulo, Brazil]. Rev Saude Publica 41 Suppl 2: 39-46. PubMed: 18094785.
52. Veloso VG, Portela MC, Vasconcellos MT, Matzenbacher LA, Vasconcelos AL et al. (2008) HIV testing among pregnant women in Brazil: rates and predictors. Rev Saude Publica 42: 859-867. doi: 10.1590/S0034-89102008000500011. PubMed: 18833385.
53. Tebit DM, Arts EJ (2011) Tracking a century of global expansion and evolution of HIV to drive understanding and to combat disease. Lancet Infect Dis 11: 45-56. doi:10.1016/S1473-3099(10)70186-9. PubMed: 21126914.
54. Brigido LF, Franco HM, Custodio RM, Oliveira CA, JL PF, et al. (2005) Molecular characteristics of HIV type 1 circulating in Sao Paulo, Brazil: AIDS Res Hum Retroviruses 21: 673-682
55. Alencar CS, Sabino EC, Carvalho SM, Leao SC, Carneiro-Proietti AB et al. (2013) HIV Genotypes and Primary Drug Resistance Among HIV-Seropositive Blood Donors in Brazil: Role of Infected Blood Donors as Sentinel Populations for Molecular Surveillance of HIV. J Acquir Immune Defic Syndr 63: 387-392. doi:10.1097/QAI.0b013e31828ff979. PubMed: 23507660.
56. Stefani MM, Pereira GA, Martelli CM, Shindo N, Galvão-Castro B (2000) Evidence of HIV-1 genetic diversity among pregnant women with AIDS or infected with HIV-1 in Central Brazil. J Acquir Immune Defic Syndr 23: 205-207. doi:10.1097/00042560-200002010-00015. PubMed: 10737438.
57. Bello G, Eyer-Silva WA, Couto-Fernandez JC, Guimarães ML, Chequer-Fernandez SL et al. (2007) Demographic history of HIV-1 subtypes B and F in Brazil. Infect Genet Evol 7: 263-270. doi:10.1016/j.meegid.2006.11.002. PubMed: 17150415.
58. Stefani MM, Pereira GA, Lins JA, Alcantara KC, Silveira AA et al. (2007) Molecular screening shows extensive HIV-1 genetic diversity in Central West Brazil. J Clin Virol 39: 205-209. doi:10.1016/j.jcv.2007.04.012. PubMed: 17537671.
59. Sabino EC, Shpaer EG, Morgado MG, Korber BT, Diaz RS et al. (1994) Identification of human immunodeficiency virus type 1 envelope genes recombinant between subtypes B and F in two epidemiologically linked individuals from Brazil. J Virol 68: 6340-6346. PubMed: 8083973.
60. De Sá Filho DJ, Sucupira MC, Caseiro MM, Sabino EC, Diaz RS et al. (2006) Identification of two HIV type 1 circulating recombinant forms in Brazil. AIDS Res Hum Retrovir 22: 1-13. doi:10.1089/aid.2006.22.1. PubMed: 16438639.
61. Guimarães ML, Eyer-Silva WA, Couto-Fernandez JC, Morgado MG (2008) Identification of two new CRF-BF in Rio de Janeiro State, Brazil. AIDS 22: 433-435. doi:10.1097/QAD.0b013e3282f47ad0. PubMed: 18195572.
62. Sanabani SS, Pastena ER, Neto WK, Martinez VP, Sabino EC. (2010) Characterization and frequency of a newly identified HIV-1 BF1 intersubtype circulating recombinant form in Sao Paulo, Brazil. Virol J 7: 74. doi:10.1186/1743-422X-7-74. PubMed: 20398371.
63. Pereira G, Cunha A, Moreira M, Oliveira S, Freitas M et al. (2011) Perspectivas para o controle da transmissão vertical do HIV no Brasil. In Saúde Brasil: uma análise da situação de saúde e de evidências selecionadas de impacto de ações de vigilância em saúde; Brasília Ministério da Saúde. pp. 335-345
64. Gouws E, Mishra V, Fowler TB (2008) Comparison of adult HIV prevalence from national population-based surveys and antenatal clinic surveillance in countries with generalised epidemics: implications for calibrating surveillance data. Sex Transm Infect 84 Suppl 1: i17-i23. doi:10.1136/sti.2007.026815. PubMed: 18647861.
65. Karita E, Price M, Hunter E, Chomba E, Allen S et al. (2007) Investigating the utility of the HIV-1 BED capture enzyme immunoassay using cross-sectional and longitudinal seroconverter specimens from Africa. AIDS 21: 403-408. doi:10.1097/QAD.0b013e32801481b7. PubMed: 17301558.
66. CDC (2006) Interim recommendations for the use of the BED capture enzyme immunoassay for incidence estimation and surveillance. Surveillance and Survey and the Laboratory working groups to the Office of the Global AIDS.